ERO1L anticorps (C-Term)
Aperçu rapide pour ERO1L anticorps (C-Term) (ABIN2262067)
Antigène
Voir toutes ERO1L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 349-379, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- ERO1L, CT (ERO1L, ERO1-like protein alpha, Endoplasmic oxidoreductin-1-like protein, Oxidoreductin-1-L-alpha)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- ERO1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 349-379 amino acids from the C-terminal region of human ERO1L.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ERO1L (ERO1-Like Protein alpha (ERO1L))
-
Autre désignation
- ERO1L
-
NCBI Accession
- NP_055399
-
UniProt
- Q96HE7
-
Pathways
- Peptide Hormone Metabolism, ER-Nucleus Signaling, Brown Fat Cell Differentiation
Antigène
-